[Skip to Content]
[Skip to Content Landing]
February 1976


Arch Gen Psychiatry. 1976;33(2):215. doi:10.1001/archpsyc.1976.01770020053008

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Multiple Errors.—In the article, "Amitriptyline-Perphenazine Interaction in Ambulatory Schizophrenic Patients: A Controlled Study of Drug Interaction," published in the October Archives (32:1295-1307, 1975), the following errors occurred:

On p 1295, in line 5 of the synopsis-abstract, the dosage of amitriptyline-perphenazine should have read 125 —20 mg/day, not 20 mg/day. The same dosage error occurred on p 1296, in column 1, in the second line from the bottom of the section titled "Study Design."

On p 1299, in column 1, line 10 should have begun —.32, not +.32.

On p 1307, the second entry under the listing of "Nonproprietary Names and Trademarks of Drugs" should have read "Amitriptyline hydrochloride—Elavil." As published, the nonproprietary name was incorrectly given as "Chlorpromazine hydrochloride."

First Page Preview View Large
First page PDF preview
First page PDF preview